STOCK TITAN

Cognex (CGNX) vice president exercises options, sells 20,252 shares of stock

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Cognex Corp vice president Darren Marc Long reported a combination of option exercises and share sales in company stock. On May 27, 2026, he exercised non-qualified stock options covering 18,673 shares of common stock at strike prices of $49.12, $51.49, and $56.44 per share.

On the same date, he completed open-market sales totaling 20,252 shares of common stock at prices of $66.5201 and $66.3215 per share. After these transactions, Long directly held 5,569 shares of Cognex common stock. The filing also lists prior grants of stock options and restricted stock units as part of his ongoing equity compensation.

Positive

  • None.

Negative

  • None.
Insider Long Darren Marc
Role Vice President
Sold 20,252 shs ($1.34M)
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) 5,498 $0.00 --
Exercise Non-Qualified Stock Option (right to buy) 8,675 $0.00 --
Exercise Non-Qualified Stock Option (right to buy) 4,500 $0.00 --
Exercise Common Stock 4,500 $56.44 $254K
Sale Common Stock 4,500 $66.3215 $298K
Exercise Common Stock 8,675 $51.49 $447K
Sale Common Stock 8,675 $66.3215 $575K
Exercise Common Stock 5,498 $49.12 $270K
Sale Common Stock 5,498 $66.3215 $365K
Sale Common Stock 1,579 $66.5201 $105K
Grant/Award Non-Qualified Stock Option (right to buy) 7,231 $0.00 --
Grant/Award Restricted Stock Unit 11,211 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 31,095 $0.00 --
Grant/Award Restricted Stock Unit 9,080 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 34,271 $0.00 --
Grant/Award Restricted Stock Unit 3,169 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 23,981 $0.00 --
Grant/Award Restricted Stock Unit 2,500 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 20,328 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 16,658 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 10,758 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 8,675 $0.00 --
Grant/Award Non-Qualified Stock Option (right to buy) 4,500 $0.00 --
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 11,160 shares (Direct, null); Common Stock — 10,069 shares (Direct, null); Restricted Stock Unit — 11,211 shares (Direct, null)
Footnotes (1)
  1. The options vest in three equal annual installments on the third, fourth and fifth anniversaries of the grant date (May 9, 2022). The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019). The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
Shares sold 20,252 shares Total Cognex common stock sold on May 27, 2026
Sale price block 1 $66.5201 per share Open-market sale of 1,579 Cognex shares
Sale price blocks 2–4 $66.3215 per share Open-market sales of 5,498, 8,675 and 4,500 shares
Options exercised 18,673 shares Total common shares from option exercises on May 27, 2026
Strike price 1 $49.12 per share Non-qualified stock option exercise price
Strike price 2 $51.49 per share Non-qualified stock option exercise price
Strike price 3 $56.44 per share Non-qualified stock option exercise price
Shares held after 5,569 shares Direct Cognex common stock ownership after transactions
Non-Qualified Stock Option (right to buy) financial
"security_title: "Non-Qualified Stock Option (right to buy)""
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit""
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion""
grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Long Darren Marc

(Last)(First)(Middle)
1 VISION DRIVE

(Street)
NATICK MASSACHUSETTS 01760

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Vice President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2018
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/27/2026M4,500A$56.4410,069D
Common Stock05/27/2026S4,500D$66.32155,569D
Common Stock05/27/2026M8,675A$51.4914,244D
Common Stock05/27/2026S8,675D$66.32155,569D
Common Stock05/27/2026M5,498A$49.1211,067D
Common Stock05/27/2026S5,498D$66.32155,569D
Common Stock05/27/2026S1,579D$66.52013,990D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy)$33.0402/18/2025A31,09502/18/202602/18/2035Common Stock31,095$0.031,095D
Non-Qualified Stock Option (right to buy)$39.4402/20/2024A34,27102/20/202502/20/2034Common Stock34,271$0.034,271D
Non-Qualified Stock Option (right to buy)$47.2102/21/2023A20,32802/21/202402/21/2033Common Stock20,328$0.020,328D
Non-Qualified Stock Option (right to buy)$49.1205/09/2022A16,65805/09/202505/09/2032Common Stock16,658$0.016,658D
Non-Qualified Stock Option (right to buy)$49.1205/27/2026M5,49805/09/2025(1)05/09/2032Common Stock5,498$0.011,160D
Non-Qualified Stock Option (right to buy)$50.0108/07/2023A23,98108/07/202708/07/2033Common Stock23,981$0.023,981D
Non-Qualified Stock Option (right to buy)$51.4902/19/2019A8,67502/19/202002/19/2029Common Stock8,675$0.08,675D
Non-Qualified Stock Option (right to buy)$51.4905/27/2026M8,67502/19/2020(2)02/19/2029Common Stock8,675$0.00D
Non-Qualified Stock Option (right to buy)$56.4402/20/2018A4,50002/20/201902/20/2028Common Stock4,500$0.04,500D
Non-Qualified Stock Option (right to buy)$56.4405/27/2026M4,50002/20/2019(3)02/20/2028Common Stock4,500$0.00D
Non-Qualified Stock Option (right to buy)$57.0902/17/2026A7,23102/17/202702/17/2036Common Stock7,231$0.07,231D
Non-Qualified Stock Option (right to buy)$64.4302/22/2022A10,75802/22/202302/22/2032Common Stock10,758$0.010,758D
Restricted Stock Unit$0.008/07/2023A2,50008/07/202408/07/2026Common Stock2,500$0.02,500D
Restricted Stock Unit$0.002/20/2024A3,16902/20/202502/20/2027Common Stock3,169$0.03,169D
Restricted Stock Unit$0.002/18/2025A9,08002/18/202602/18/2028Common Stock9,080$0.09,080D
Restricted Stock Unit$0.002/17/2026A11,21102/17/202702/17/2029Common Stock11,211$0.011,211D
Explanation of Responses:
1. The options vest in three equal annual installments on the third, fourth and fifth anniversaries of the grant date (May 9, 2022).
2. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).
3. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
Darren Marc Long05/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Cognex (CGNX) executive Darren Marc Long report in this Form 4?

Darren Marc Long reported exercising stock options and selling Cognex common shares. The filing shows option exercises for 18,673 shares and open-market sales of 20,252 shares on May 27, 2026, as part of his ongoing equity compensation activity.

How many Cognex (CGNX) shares did Darren Marc Long sell and at what prices?

He sold a total of 20,252 Cognex common shares in open-market transactions. The trades were executed at prices of $66.5201 and $66.3215 per share, reflecting multiple sale blocks on May 27, 2026, as disclosed in the Form 4 filing.

What stock options did Darren Marc Long exercise in Cognex (CGNX) shares?

He exercised non-qualified stock options covering 18,673 Cognex common shares. The option exercise prices were $49.12, $51.49, and $56.44 per share, converting derivative awards into common stock before the same-day sales recorded in the Form 4.

How many Cognex (CGNX) shares does Darren Marc Long hold after these transactions?

Following the reported transactions, he directly holds 5,569 Cognex common shares. This post-transaction balance comes after exercising options and selling 20,252 shares, as detailed in the ownership column of the Form 4 filing.

What type of compensation awards are disclosed for Darren Marc Long at Cognex (CGNX)?

The filing lists non-qualified stock options and restricted stock units as part of his compensation. It shows multiple grants over several years, including RSUs and options with various exercise prices and vesting schedules tied to specific grant and anniversary dates.

Does the Cognex (CGNX) Form 4 show only sales, or also acquisitions by Darren Marc Long?

It shows both acquisitions and sales. Long acquired shares by exercising non-qualified stock options for 18,673 shares, then sold 20,252 shares in open-market transactions, resulting in a mixed pattern of derivative exercise and share disposition on May 27, 2026.